IDEXX Laboratories' earnings per share fell 34% year over year in the fourth quarter, but the veterinary test specialist's numbers require some adjustments. Starting this year, IDEXX will sell its ...
IDEXX reported lower full-year organic revenue growth due to reduced U.S. clinical visits. Weak consumer sentiment and ongoing staffing challenges may continue to impact clinical visits in the near ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback